Search for: "PREFERRED PHARMACEUTICALS, INC" Results 181 - 200 of 434
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2014, 1:39 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
15 Apr 2014, 6:55 am
Bayer Healthcare Pharmaceuticals, Inc., 2014 U.S. [read post]
11 Apr 2014, 11:29 am
Finally, United States Patent No. 6,468,559 (“Chen”) […] disclosed a preferred embodiment in which “a dosage form of the invention is administered to a patient . . . preferably once a month. [read post]
3 Apr 2014, 5:00 am
Jan. 30, 2014) (“Actos”); In re Ethicon, Inc. [read post]
28 Mar 2014, 5:33 pm
   Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and… [read post]
11 Mar 2014, 1:35 pm
  Her post is about the First Amendment implications of the FDA's recent draft guidance on manufacturer distribution of scientific articles and textbooks, a proposal that alters, but does not fundamentally change the FDA's previous guidance on this subject that we discussed back in 2009.Take it away Lindsey:********************Last week, the FDA released new draft guidelines that represent its latest recommendations for what drug and device manufacturers should do when they wish to distribute… [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
25 Feb 2014, 2:49 pm
The U.S. company Merck, Inc. is active in Germany under the name “MSD Shark & Dohme”. [read post]
25 Jan 2014, 9:43 am by Barry Barnett
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
13 Jan 2014, 4:02 am
Take for example, the pharmaceuticals case of Cephalon Inc v Orchid Europe Ltd [2010] EWHC 2945 (Pat) [briefly noted on PatLit here] in which Floyd J (as he was) treated the issue of who is likely to suffer the most irreparable harm as the key factor in the balance of convenience assessment itself: "Balance of convenienceThere is no dispute as to the approach which I should apply. [read post]
15 Dec 2013, 4:00 am by Administrator
Pharmaceuticals: GenericsKatz Group Canada Inc. [read post]